【24h】

Thromboprophylaxis in surgical patients.

机译:外科手术患者的血栓预防。

获取原文
获取原文并翻译 | 示例
           

摘要

Venous thromboembolism is the most common preventable cause of death in surgical patients. Thromboprophylaxis, using mechanical methods to promote venous outflow from the legs and antithrombotic drugs, provides the most effective means of reducing morbidity and mortality in these patients. Despite the evidence supporting thromboprophylaxis, it remains underused because surgeons perceive that the risk of venous thromboembolism is not high enough to justify the potential hemorrhagic complications of anticoagulant use. The risk of venous thromboembolism is determined by patient characteristics and by the type of surgery that is performed. In this paper we identify the risk factors for venous thromboembolism and provide a scheme for stratifying surgical patients according to their risk. We describe the mechanism of action of the various forms of thromboprophylaxis and outline the evidence supporting thromboprophylaxis in different surgical settings. Finally, we recommend optimal forms of thromboprophylaxisin patients who undergo various types of surgery. Intermittent pneumatic compression, with or without elastic stockings, can be used for thromboprophylaxis in patients who undergo neurosurgical procedures; for patients who undergo vascular or cardiovascular procedures, long-term acetylsalicylic acid should be used for thromboprophylaxis. Low-molecular-weight heparin (LMWH) or warfarin is the choice for patients with spinal cord operations and all patients with major trauma who do not have contraindications to anticoagulation should receive thromboprophylaxis with LMWH.
机译:静脉血栓栓塞是外科手术患者最常见的可预防死亡原因。预防血栓形成,采用机械方法以促进腿部静脉流出和使用抗血栓形成药物,是降低这些患者发病率和死亡率的最有效手段。尽管有证据支持预防血栓形成,但仍未得到充分利用,因为外科医生认为静脉血栓栓塞的风险尚不足以证明使用抗凝剂可能引起的出血并发症。静脉血栓栓塞的风险取决于患者的特征和所进行的手术类型。在本文中,我们确定了静脉血栓栓塞的危险因素,并根据手术患者的风险提供了分层方案。我们描述了各种形式的预防血栓形成的作用机理,并概述了在不同手术环境中支持预防血栓形成的证据。最后,我们建议进行各种类型手术的患者预防血栓形成的最佳形式。间歇性气动加压(带或不带弹力袜)可用于接受神经外科手术的患者的血栓预防;对于接受血管或心血管手术的患者,应长期使用乙酰水杨酸预防血栓形成。低分子肝素(LMWH)或华法林是脊髓手术患者的选择,所有没有抗凝禁忌症的重度创伤患者均应接受LMWH预防血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号